Clicky

A Simple Blood Test Could Predict Your Risk of Alzheimer’s

Default Icon in Brain Health
A Black adult son hugging senior Black mother, who may have Alzheimer’s

Alzheimer’s doesn’t arrive all at once. It begins quietly — with small lapses, misplaced keys, repeated questions, or moments where someone loses their train of thought.1 For years, families misunderstand these changes as stress or aging. By the time symptoms become undeniable, the condition is already far along.1

But researchers are now developing something that could change everything: a simple blood test that predicts Alzheimer’s years before the first signs appear.2

For communities disproportionately affected by delayed diagnoses, including Black and Brown families whose symptoms are often overlooked, dismissed, or misattributed, early detection could be lifesaving.3

To understand why this blood test matters, we first have to understand what the brain does, what Alzheimer’s does to it, and why timing is everything.

How the Brain Works and Why It’s So Vulnerable

The brain is the command center of your entire body.4 It stores your memories, interprets your emotions, controls your heartbeat and breathing, and allows you to think, learn, move, speak, and recognize the people you love.4 Its network of billions of neurons communicate constantly through tiny electrical and chemical signals.4

But this system is delicate. When brain cells become damaged or when communication between them breaks down, every part of life can be affected.4 Alzheimer’s is one of the leading diseases that disrupt this intricate system.

What Alzheimer’s Disease Really Is

Alzheimer’s is the most common form of dementia.1 It slowly destroys memory, thinking skills, and eventually the ability to perform daily tasks.1 It develops over many years in three key ways:

1. A buildup of harmful proteins

  • Two proteins — amyloid and tau — begin to accumulate in the brain.1
  • Amyloid forms sticky plaques that disrupt communication between brain cells.1
  • Tau forms tangles inside the cells, damaging their internal structure.1

2. Brain cell damage 

Over time, neurons lose their ability to communicate and eventually die.1

3. Brain shrinkage

As brain cells die, critical memory and thinking regions shrink, leading to worsening symptoms.1

How it feels in the real world:

People may repeat the same questions, lose track of conversations, forget familiar faces, or struggle with tasks they’ve always done. Eventually, Alzheimer’s affects movement, swallowing, and the ability to live independently.1

Early detection is crucial, but historically, it’s been one of the hardest diseases to diagnose early.1

How Alzheimer’s Has Traditionally Been Diagnosed

For decades, diagnosing Alzheimer’s involved a combination of cognitive testing and expensive or invasive procedures.5 These methods can be accurate, but they’re not always accessible.

Cognitive Exams

Doctors ask questions to evaluate memory, thinking, and problem-solving.5 These tests help identify cognitive decline but can’t confirm the underlying cause.5

Brain Imaging

  • MRI or CT scans look for brain shrinkage.5
  • PET scans can detect amyloid buildup, but they cost thousands and are not widely available.5

Spinal Tap (Lumbar Puncture)

This test checks for amyloid and tau in the cerebrospinal fluid. It’s accurate but invasive and not something many people are eager to undergo.5

Because of cost, access, and medical bias, many Black and Brown people never receive these advanced tests, or receive them too late. This is why the new blood test is such a breakthrough.5

The New Blood Test That Could Predict Alzheimer’s

Researchers have discovered that Alzheimer’s-related proteins, especially p-tau217, a form of tau strongly linked to early Alzheimer’s, can be measured in the blood.2 This means a simple blood draw could detect Alzheimer’s even before major symptoms appear.2

Why the blood test matters:

  • It’s easier: No spinal taps, no long scans.2
  • It’s cheaper: A fraction of the cost of imaging.2
  • It’s earlier: Detects changes before memory loss becomes severe.2
  • It’s more accessible: Especially for patients in communities with fewer specialists.2

Though the test is still being studied and rolled out in stages, early research shows accuracy rates comparable to PET scans, which could revolutionize how we diagnose Alzheimer’s.2

Why This Matters for Black and Brown Communities

Black Americans are twice as likely to develop Alzheimer’s compared to white Americans, yet they are far less likely to receive an early or accurate diagnosis.3

This gap isn’t caused by biology alone. It’s shaped by the environments people live in, the healthcare systems they navigate, and the way their symptoms are interpreted.3

Several barriers drive this disparity, many of which show up long before memory loss becomes noticeable:

  • Underdiagnosis and medical bias: Early symptoms in Black patients are more likely to be minimized or misinterpreted. Instead of being taken seriously, cognitive changes are often labeled as stress, aging, or “normal forgetfulness,” delaying crucial testing.3

  • Limited access to specialists: Neurologists and memory clinics are less available in many predominantly Black and Brown communities.3 Without access to experts trained to spot early Alzheimer’s, families often go years without answers.3

  • Higher burden of chronic conditions: Conditions like hypertension, diabetes, stroke, and kidney disease occur at higher rates in Black adults and each one increases the risk of cognitive decline.3 These conditions can also mask or complicate early Alzheimer’s symptoms.3

  • Environmental stressors: Chronic exposure to environmental pollutants, neighborhood stress, and decades of cumulative racism can elevate inflammation and disrupt brain health in ways researchers are only beginning to fully understand.3

Together, these factors create a pattern where Black and Brown adults are diagnosed later, often when symptoms are moderate or advanced and treatment options are more limited.3

That’s why a simple blood test matters so much. A screening that’s affordable, accessible, and less invasive could close years of diagnostic delay, giving families time to plan, initiate treatment earlier, and maintain quality of life for longer.

This isn’t just medical progress, it’s an opportunity to correct a long-standing injustice in brain health.

Signs and Symptoms Worth Noticing

Even as early detection improves, paying attention to everyday changes remains important. Symptoms may include:

  • Memory lapses that disrupt daily life.6
  • Difficulty planning or problem-solving.6
  • Trouble finding words.6
  • Forgetting appointments or conversations.6
  • Changes in mood or personality.6
  • Confusion about time or place.6
  • Withdrawal from work or social activities.6

If you’re seeing these patterns, either in yourself or someone you love. talk to your doctor and ask about screening options.

How to Talk to Your Doctor About Alzheimer’s Risk

Bring these questions to your next appointment:

  • “Can we do a cognitive screening to check my memory and thinking skills”?
  • “Based on my family history or symptoms, should I be screened for early Alzheimer’s”?
  • “Can you tell me whether the new blood tests are available in our area”?
  • “What lifestyle changes can support brain health now”?

If a doctor dismisses your concerns, it’s appropriate to say: “I know my community faces higher rates of Alzheimer’s, and I’d like a thorough evaluation.”

Your concerns are valid and you deserve to be taken seriously.

Protecting Your Brain Health Starts Now

Alzheimer’s research is advancing quickly, and this new blood test brings us one step closer to catching the disease before it steals years of life and memory. Early detection opens the door to treatments, lifestyle changes, and resources that can slow progression and support families.

For communities facing historic health inequities, access to these advances is essential.

References

  1. Alzheimer’s Association. (2025). What is Alzheimer’s Disease? Retrieved from Alzheimer’s Association: https://www.alz.org/alzheimers-dementia/what-is-alzheimers
  2. FDA. (2025, May 16). FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease. Retrieved from U.S. Food and Drug Administration: https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease
  3. NIH. (2021, December 16). Data shows racial disparities in Alzheimer’s disease diagnosis between Black and white research study participants. Retrieved from NIH: National Institute on Aging: https://www.nia.nih.gov/news/data-shows-racial-disparities-alzheimers-disease-diagnosis-between-black-and-white-research
  4. InformedHealth.org. (2021, September 29). In brief: How does the brain work? Retrieved from Institute for Quality and Efficiency in Health Care (IQWiG): https://www.ncbi.nlm.nih.gov/books/NBK279302/
  5. NIH. (2022, December 8). How Is Alzheimer’s Disease Diagnosed? Retrieved from NIH: National Institute on Aging: https://www.nia.nih.gov/health/alzheimers-symptoms-and-diagnosis/how-alzheimers-disease-diagnosed
  6. Alzheimer’s Association. (2025). 10 Early Signs and Symptoms of Alzheimer’s and Dementia. Retrieved from Alzheimer’s Association: https://www.alz.org/alzheimers-dementia/10_signs

Download Every Kidney Counts Assets

Download Rooted Resilience Assets

Skip to content